PBAC's latest decision on Milk powder synthetic low calcium: Recommended with restriction (2020). Considered for Dietary management of hypercalcaemia in patients under the age of four years (inclusive).
PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
1
first 2020
Submissions
1
2020 → 2020
Eligible population
Patients under the age of four years (inclusive) requiring dietary management of hypercalcaemia.
Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Other
Economic model
Not modelled
ICER note
Not a clinical/economic submission; formulation change only. No ICER calculated.